[HTML][HTML] Identification of attention-deficit hyperactivity disorder based on the complexity and symmetricity of pupil diameter

S Nobukawa, A Shirama, T Takahashi, T Takeda… - Scientific Reports, 2021 - nature.com
Adult attention-deficit/hyperactivity disorder (ADHD) frequently leads to psychological/social
dysfunction if unaddressed. Identifying a reliable biomarker would assist the diagnosis of …

Individualized functional connectome identified generalizable biomarkers for psychiatric symptoms in transdiagnostic patients

M Li, L Dahmani, CS Hubbard, Y Hu, M Wang… - …, 2023 - nature.com
Substantial clinical heterogeneity and comorbidity inherent amongst mental disorders limit
the identification of neuroimaging biomarkers that can reliably track clinical symptoms …

Adult ADHD diagnosis, symptoms of impulsivity, and emotional dysregulation in a clinical sample of outpatients consulting for a behavioral addiction

S El Archi, S Barrault, M Garcia… - Journal of Attention …, 2023 - journals.sagepub.com
Objective: This study aimed to investigate ADHD in adult outpatients seeking treatment for a
behavioral addiction and to identify the specificity of psychopathological features if the …

Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective

J Schein, LA Adler, A Childress… - Journal of managed …, 2022 - jmcp.org
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is associated with
substantial clinical burden as individuals transition to adulthood, including higher rates of …

[HTML][HTML] Psychiatric symptoms and entrepreneurial intention: The role of the behavioral activation system

YK Leung, IHA Franken, AR Thurik - Journal of Business Venturing Insights, 2020 - Elsevier
Both the scientific literature and the popular press have recently started to associate
entrepreneurship with symptoms of mental disorders. In addition, there is an emerging …

[HTML][HTML] Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate

JR Gutiérrez-Casares, J Quintero, G Jorba… - Frontiers in …, 2021 - frontiersin.org
Regulatory agencies encourage computer modeling and simulation to reduce the time and
cost of clinical trials. Although still not classified in formal guidelines, system biology-based …

Cannabis for the treatment of attention deficit hyperactivity disorder: a report of 3 cases

H Mansell, D Quinn, LE Kelly, J Alcorn - Medical cannabis and …, 2022 - karger.com
Attention deficit hyperactivity disorder (ADHD) is a chronic neurobehavioral disorder that is
highly prevalent in children and adults. An increasing number of patients with ADHD are self …

[HTML][HTML] Adult attention deficit hyperactivity disorder: a comprehensive review

OC Williams, S Prasad, A McCrary… - Annals of Medicine …, 2023 - journals.lww.com
Attention deficit hyperactivity disorder (ADHD) is a common childhood disorder, with only 2–
3% prevalence into adulthood. The epidemiology and proposed causes of ADHD are …

[HTML][HTML] Psychiatric comorbidities in adult attention-deficit/hyperactivity disorder: prevalence and patterns in the routine clinical setting

T Ohnishi, H Kobayashi, T Yajima… - Innovations in clinical …, 2019 - ncbi.nlm.nih.gov
Objective: While attention-deficit/hyperactivity disorder (ADHD) is associated with a high
prevalence of comorbid psychiatric disorders in every age group, the etiology and …

[HTML][HTML] A meta-analysis on the therapeutic efficacy of repetitive transcranial magnetic stimulation for cognitive functions in attention-deficit/hyperactivity disorders

YH Chen, SC Liang, CK Sun, YS Cheng, RF Tzang… - BMC psychiatry, 2023 - Springer
Background Therapeutic efficacies of repetitive transcranial magnetic stimulation (rTMS) for
improving cognitive functions in patients with deficit/hyperactivity disorder (ADHD) remained …